Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled…

Overview of attention for article published in The Lancet Respiratory Medicine, January 2026

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news: 1 news outlet
twitter: 5 X users

bluesky: 2 Bluesky users

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 2 Bluesky posts from 2 Bluesky users, with an upper bound of 5,222 followers.

Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial www.thelancet.com/journals/lan...

📊 New phase 4 RCT: Budesonide–formoterol versus terbutaline reliever in adults with #asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA) www.thelancet.com/journals/lan...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.